GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
Canadian Cancer Trials Group
Canadian Cancer Trials Group
University of Southern California
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
TCR2 Therapeutics
Essen Biotech
BioEclipse Therapeutics
Gilead Sciences
Fate Therapeutics
Fate Therapeutics
Fred Hutchinson Cancer Center